Pembrolizumab: Solution concentrate for I.V. infusion 100 mg in 4 mL; Keytruda® Page last updated: 20 March 2020 Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB) Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)